Angiogenesis plays a fundamental role in a number of processes such as development, wound healing and tumorigenesis. Although endothelial cell (EC) proliferation is a key event in angiogenesis, little is known about the regulation of molecules critical for this process. We postulate that 1) cell cycle proteins that control G1 transition of the cell cycle are regulated during angiogenesis and 2) some anti-angiogenic agents that inhibit EC growth affect proteins critical for G1 progression. We also postulate that 3) the extracellular matrix environment is important in regulating EC growth and that 4) distinct integrin receptors are responsible for triggering cell cycle proteins during this process. To investigate these hypotheses, we will monitor G1 phase cell cycle proteins during EC proliferation in vivo and in vitro. Initially we will establish a microvascular EC line with expanded life span by introducing telomerase. We will use these cells to determine 1) what G1 cell cycle proteins are expressed during mitogen-induced EC proliferation on different matrix proteins; 2) identify the integrins involved; 3) determine how integrin activation affects cell cycle proteins; 4) investigate the cell cycle events following treatment with anti-angiogenic agents. Furthermore, we will determine the expression patterns of G1 cell cycle proteins during angiogenesis in vivo. We also investigate the role of these proteins in angiogenesis by examining mice null for cell cycle proteins. Data derived from this study should provide specific insights to the mechanism of integrin-induced cell cycle progression and the role of cell cycle proteins during angiogenesis. Understanding the mechanism of anti-angiogenic agents and the molecular links between ligation and cell cycle machinery will aid in the development of new approaches to control angiogenesis-associated pathologies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA083311-02
Application #
6350396
Study Section
Pathology A Study Section (PTHA)
Program Officer
Lohrey, Nancy
Project Start
2001-02-01
Project End
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
2
Fiscal Year
2001
Total Cost
$40,196
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Smith, Laura L; Coller, Hilary A; Roberts, James M (2003) Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 5:474-9